Pharmacokinetic herb-drug interactions: are preventive screenings necessary and appropriate?

Planta medica
Veronika ButterweckMatthias Unger

Abstract

Pharmacokinetic interactions often occur as a result of activity changes of drug-metabolizing and transporting proteins, especially cytochrome P450 (CYP) isoenzymes and P-glycoprotein (P-gp). The activity of these enzymes and drug transporters can be enhanced or inhibited by synthetic drugs as well as by natural products. Since the number of herb-drug interactions has increased in recent years, systematic in vitro screenings and more clinical studies to identify such interactions were proposed for herbal medicinal products. However, previous results regarding this issue are not only contradictory but also of less predictability. One reason for the discrepancies could be the lack of validation of the recommended in vitro tests. Furthermore, it has to be considered that pharmacokinetic drug interactions are not only mediated by herbal medicines but also by several foods, beverages and life-style products. Since herbal medicines are considered to have a broad therapeutic range, a preventive risk assessment for pharmacokinetic drug interactions should first be realized for synthetic drugs with a narrow therapeutic index. Efforts to identify all possible interactions will lead to limitless investigations and to inconsistent decisions.

Citations

Aug 21, 2007·Wiener medizinische Wochenschrift·Johannes Freudenstein, Thomas Nisslein
Nov 3, 2006·The American Journal of Chinese Medicine·Hsiu-Mei ChiangYu-Chi Hou
May 16, 2008·Clinical Pharmacokinetics·Veronika Butterweck, Hartmut Derendorf
May 19, 2005·Toxicological Reviews·Rupika Delgoda, Andrew C G Westlake
Nov 29, 2007·Therapeutic Drug Monitoring·Souad SkalliRachida Soulaymani
Jul 20, 2013·Drug Metabolism Reviews·Matthias Unger
Dec 29, 2009·Progress in Neuro-psychopharmacology & Biological Psychiatry·Mehdi SayyahAlireza Malayeri
Mar 1, 2007·Comparative Biochemistry and Physiology. Part D, Genomics & Proteomics·Michele M SkopecM Denise Dearing
Feb 26, 2016·Drug Metabolism Reviews·Thomas VanhoveDirk R J Kuypers
Nov 15, 2006·Journal of Clinical Pharmacology·S U Mertens-TalcottV Butterweck
Jul 19, 2006·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Rose HayeshiAnna-Lena B Ungell
Jan 24, 2006·Phytomedicine : International Journal of Phytotherapy and Phytopharmacology·V Schulz
Mar 30, 2005·Expert Opinion on Drug Safety·Elizabeth M Williamson
Feb 1, 2015·La Revue de médecine interne·S MoulyJ-F Bergmann
Oct 4, 2016·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Stéphane MoulyJ-F Bergmann
May 25, 2005·Electrophoresis·Matthias UngerUlrike Holzgrabe
May 13, 2020·Current Drug Metabolism·Sara Batista do NascimentoWhocely Victor de Castro
Jul 28, 2005·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Rainer Nowack, Barbara Nowak
Oct 20, 2020·Revista Brasileira De Farmacognosia : Orgão Oficial Da Sociedade Brasileira De Farmacognosia·Taiwo O ElufioyeAdeboye Adejare
Jan 19, 2021·Biomedical Chromatography : BMC·Sara Batista do NascimentoWhocely Victor de Castro
Feb 12, 2021·Journal of Multidisciplinary Healthcare·Nur AzizahAliya Nur Hasanah

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.